Table 1.
Patient | Gender | Age (years) | Ethnicity | HIV antibody | CD4 count (cells/μL) | FTA-ABS a | RPR b titer | Affected eye | Treatment | Pre-treatment visual acuity | Post-treatment visual acuity |
---|---|---|---|---|---|---|---|---|---|---|---|
1 |
Male |
47 |
Caucasian |
Negative |
n/a |
Positive |
1:128 |
Right |
Intravenous penicillin |
20/50 |
20/20 |
2 |
Male |
60 |
Caucasian |
Positive |
600 |
Positive |
Nonreactive |
Right |
Intravenous ceftriaxone |
20/63 |
20/25 |
3 | Male | 50 | Caucasian | Positive | 830 | Positive | 1:4,096 | Left | Intravenous penicillin | 20/60 | 20/25 |
aFluorescent treponemal antibody-absorption; brapid plasma reagin.